Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$0.29 - $0.64 $537 - $1,185
1,852 Added 2.03%
93,056 $27,000
Q4 2022

Feb 10, 2023

SELL
$0.38 - $22.5 $126 - $7,470
-332 Reduced 0.36%
91,204 $35,000
Q3 2022

Nov 14, 2022

BUY
$0.73 - $23.4 $944 - $30,279
1,294 Added 1.43%
91,536 $65,000
Q2 2022

Aug 12, 2022

SELL
$0.66 - $1.81 $2,201 - $6,036
-3,335 Reduced 3.56%
90,242 $73,000
Q1 2022

May 13, 2022

SELL
$1.27 - $2.47 $8,364 - $16,267
-6,586 Reduced 6.58%
93,577 $155,000
Q4 2021

Feb 11, 2022

SELL
$2.21 - $3.22 $3,867 - $5,635
-1,750 Reduced 1.72%
100,163 $234,000
Q3 2021

Nov 12, 2021

SELL
$2.8 - $3.72 $6,784 - $9,013
-2,423 Reduced 2.32%
101,913 $317,000
Q2 2021

Aug 13, 2021

SELL
$2.61 - $4.17 $1,808 - $2,889
-693 Reduced 0.66%
104,336 $350,000
Q1 2021

May 07, 2021

BUY
$2.91 - $4.32 $806 - $1,196
277 Added 0.26%
105,029 $327,000
Q4 2020

Feb 12, 2021

BUY
$2.15 - $3.5 $4,452 - $7,248
2,071 Added 2.02%
104,752 $288,000
Q3 2020

Nov 04, 2020

SELL
$2.77 - $6.17 $6,467 - $14,406
-2,335 Reduced 2.22%
102,681 $294,000
Q2 2020

Aug 12, 2020

BUY
$0.87 - $3.13 $12,485 - $44,918
14,351 Added 15.83%
105,016 $326,000
Q1 2020

May 04, 2020

SELL
$0.73 - $1.91 $3,823 - $10,002
-5,237 Reduced 5.46%
90,665 $86,000
Q4 2019

Feb 05, 2020

BUY
$0.48 - $1.38 $20,600 - $59,225
42,917 Added 81.0%
95,902 $132,000
Q3 2019

Nov 08, 2019

SELL
$0.47 - $1.05 $172 - $386
-368 Reduced 0.69%
52,985 $25,000
Q2 2019

Aug 13, 2019

BUY
$0.65 - $2.12 $34,679 - $113,108
53,353 New
53,353 $63,000
Q2 2018

Aug 08, 2018

SELL
$2.75 - $3.85 $60,731 - $85,023
-22,084 Closed
0 $0
Q1 2018

May 07, 2018

SELL
$3.5 - $4.47 $4,158 - $5,310
-1,188 Reduced 5.1%
22,084 $77,000
Q4 2017

Feb 09, 2018

BUY
$3.29 - $5.03 $28,721 - $43,911
8,730 Added 60.03%
23,272 $99,000
Q3 2017

Nov 09, 2017

BUY
$3.15 - $4.01 $45,807 - $58,313
14,542
14,542 $56,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.